☆ 4.6 Article

miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease

MOLECULAR NEUROBIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

A Systematic Review of Circulatory microRNAs in Major Depressive Disorder: Potential Biomarkers for Disease Prognosis

Madiha Rasheed et al.

Summary: This systematic review explores the role of circulatory microRNAs (cimiRNAs) as biomarkers for the diagnosis of major depressive disorder (MDD). The study identifies dysregulated cimiRNAs in MDD patients and analyzes their involvement in molecular pathways and co-regulation with transcription factors. However, further research is needed to determine the clinical significance and therapeutic implications of these cimiRNAs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Neurosciences

ASD/OCD-Linked Protocadherin-10 Regulates Synapse, But Not Axon, Development in the Amygdala and Contributes to Fear- and Anxiety-Related Behaviors

Naosuke Hoshina et al.

Summary: This study reveals the critical role of PCDH10 in excitatory synapse development in the dorsal amygdala and its regulation of anxiety-related, fear-related, and stress-related behaviors.

JOURNAL OF NEUROSCIENCE (2022)

Add to Collection

Review Clinical Neurology

Challenges in the diagnosis of Parkinson's disease

Eduardo Tolosa et al.

Summary: Parkinson's disease is the second most common neurodegenerative disease, with efforts being made to accurately diagnose and characterize it, including validation of diagnostic criteria and identification of genetic subtypes. Progress in diagnostic biomarkers has opened up possibilities for earlier identification, recognition of diverse subtypes, and development of novel treatments.

LANCET NEUROLOGY (2021)

Add to Collection

Review Neurosciences

Drug Choices and Advancements for Managing Depression in Parkinson's Disease

Francesca Assogna et al.

CURRENT NEUROPHARMACOLOGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Drug treatment strategies for depression in Parkinson disease

Melody Ryan et al.

EXPERT OPINION ON PHARMACOTHERAPY (2019)

Add to Collection

Article Clinical Neurology

Combinatory microRNA serum signatures as classifiers of Parkinson's disease

Ketan S. Patil et al.

PARKINSONISM & RELATED DISORDERS (2019)

Add to Collection

Review Geriatrics & Gerontology

Caregiver Burden in Parkinson Disease: A Critical Review of Recent Literature

Philip E. Mosley et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2017)

Add to Collection

Editorial Material Neurosciences

A Systematic Review of Depression

Ranji Cui

CURRENT NEUROPHARMACOLOGY (2015)

Add to Collection

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Add to Collection

Article Psychiatry

Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications

Chiara Fabbri et al.

CURRENT PSYCHIATRY REPORTS (2015)

Add to Collection

Review Clinical Neurology

Depression in Parkinson disease-epidemiology, mechanisms and management

Dag Aarsland et al.

NATURE REVIEWS NEUROLOGY (2012)

Add to Collection

Article Clinical Neurology

Quality improvement in neurology: AAN Parkinson disease quality measures Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology

E. M. Cheng et al.

NEUROLOGY (2010)

Add to Collection

Article Neurosciences

Treatment strategies for Parkinson's disease

Hong Yuan et al.

NEUROSCIENCE BULLETIN (2010)

Add to Collection

Article Clinical Neurology

The Impact of Treatment of Depression on Quality of Life, Disability and Relapse in Patients with Parkinson's Disease

Matthew Menza et al.

MOVEMENT DISORDERS (2009)

Add to Collection

Article Clinical Neurology

Cognitive-behavioral therapy for depression in Parkinson's disease: A pilot study

Roseanne DeFronzo Dobkin et al.

MOVEMENT DISORDERS (2007)

Add to Collection

Article Clinical Neurology

S100B and response to treatment in major depression: a pilot study

V Arolt et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)

Add to Collection

Article Neurosciences

Neurotrophic factor S100beta in major depression

HJ Grabe et al.

NEUROPSYCHOBIOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.